News Releases
October 22, 2025
ROCHESTER, Minn. — A genomic test co-developed by Mayo Clinic and SkylineDx can identify whether people with melanoma are at low or high risk for[...]
December 1, 2017
November 29, 2017
November 15, 2017
November 13, 2017
November 10, 2017
November 9, 2017
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community